R&D Systems™ Recombinant Human PD-L1/B7-H1 Fc Chimera Protein

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

Supplier:  R&D Systems™ 156B7100

Catalog No. 156B7100

Description

Measured by its ability to inhibit anti-CD3 antibody induced IL-2 secretion in human T lymphocytes. The ED50 for this effect is 0.075-0.75 μg/mL.

Specifications

• Accession Number: Q9NZQ7
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS and NaCl.
• Molecular Weight (g/mol): M.W. (Observed): 70-75 kDa, reducing conditions; M.W. (theoretical): 52 kDa (monomer)
• Quantity: 100 μg
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.01 EU / 1 μg of the protein by the LAL method.
• Conjugate: Unconjugated
• Reconstitution: Reconstitute at 100 μg/mL in sterile PBS.
• Protein: PD-L1

• For Use With (Application): Bioactivity
• Gene ID (Entrez): 29126
• Name: B7-H1/PD-L1 Fc Chimera
• Source: Mouse myeloma cell line, NS0-derived human PD-L1/B7-H1 protein Human PD-L1 (Phe19-Thr239) (N-terminus) Accession # Q9NZQ7 DIEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)
• Structural Form: Disulfide-linked homodimer
• Gene Symbol: CD274
• Recombinant: Recombinant
• Purity or Quality Grade: >90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.